Vicarious Surgical Statistics
Share Statistics
Vicarious Surgical has 5.91M shares outstanding. The number of shares has increased by -96.2% in one year.
| Shares Outstanding | 5.91M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.3% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.04M |
| Failed to Deliver (FTD) Shares | 1.20K |
| FTD / Avg. Volume | 3.93% |
Short Selling Information
The latest short interest is 65.84K, so 1.11% of the outstanding shares have been sold short.
| Short Interest | 65.84K |
| Short % of Shares Out | 1.11% |
| Short % of Float | 2.2% |
| Short Ratio (days to cover) | 3.49 |
Valuation Ratios
The PE ratio is -0.75 and the forward PE ratio is -1.25.
| PE Ratio | -0.75 |
| Forward PE | -1.25 |
| PS Ratio | 0 |
| Forward PS | 2.1 |
| PB Ratio | 0.54 |
| P/FCF Ratio | -0.83 |
| PEG Ratio | n/a |
Enterprise Valuation
Vicarious Surgical Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 13.87, with a Debt / Equity ratio of 0.14.
| Current Ratio | 13.87 |
| Quick Ratio | 13.87 |
| Debt / Equity | 0.14 |
| Total Debt / Capitalization | 12.34 |
| Cash Flow / Debt | -4.52 |
| Interest Coverage | -3226.64 |
Financial Efficiency
Return on equity (ROE) is -0.73% and return on capital (ROIC) is -71.51%.
| Return on Equity (ROE) | -0.73% |
| Return on Assets (ROA) | -0.59% |
| Return on Capital (ROIC) | -71.51% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -550.94K |
| Employee Count | 129 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 50.11% in the last 52 weeks. The beta is 1.03, so Vicarious Surgical 's price volatility has been higher than the market average.
| Beta | 1.03 |
| 52-Week Price Change | 50.11% |
| 50-Day Moving Average | 9.84 |
| 200-Day Moving Average | 8.56 |
| Relative Strength Index (RSI) | 59.02 |
| Average Volume (20 Days) | 30.53K |
Income Statement
In the last 12 months, Vicarious Surgical had revenue of $0 and earned -$71.07M in profits. Earnings per share was $-14.7.
| Revenue | 0 |
| Gross Profit | -1.85M |
| Operating Income | -80.67M |
| Net Income | -71.07M |
| EBITDA | -69.19M |
| EBIT | - |
| Earnings Per Share (EPS) | -14.7 |
Balance Sheet
The company has $52.82M in cash and $14.83M in debt, giving a net cash position of $37.99M.
| Cash & Cash Equivalents | 52.82M |
| Total Debt | 14.83M |
| Net Cash | 37.99M |
| Retained Earnings | -132.71M |
| Total Assets | 80.62M |
| Working Capital | 55.37M |
Cash Flow
In the last 12 months, operating cash flow was -$62.30M and capital expenditures -$1.67M, giving a free cash flow of -$63.98M.
| Operating Cash Flow | -62.30M |
| Capital Expenditures | -1.67M |
| Free Cash Flow | -63.98M |
| FCF Per Share | -13.23 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
RBOT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -103.52% |
| FCF Yield | -76.25% |
Analyst Forecast
The average price target for RBOT is $10.25, which is -27.8% lower than the current price. The consensus rating is "Hold".
| Price Target | $10.25 |
| Price Target Difference | -27.8% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Jun 13, 2024. It was a backward split with a ratio of 1:30.
| Last Split Date | Jun 13, 2024 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -2.53 |
| Piotroski F-Score | 3 |